COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,837 Articles (22,553 medRxiv, 8,284 bioRxiv)

Most recent first Previous |  Page 1257: Articles 12561-12570  | Next

Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected Patients
Cantoni, D., Mayora-Neto, M., Thakur, N., Elrefaey, A. M., Newman, J., Vishwanath, S., Nadesalingam, A., Chan, A., Smith, P., Castillo-Olivares, J., Baxendale, H., Charleston, B., Heeney, J., Bailey, D., Temperton, N.
10.1101/2021.08.17.456606 — Posted: 2021-08-17
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Zhang, J., Xiao, T., Cai, Y., Lavine, C. L., Peng, H., Zhu, H., Anand, K., Tong, P., Gautam, A., Mayer, M. L., Walsh, R. M., Rits-Volloch, S., Wesemann, D. R., Yang, W., Seaman, M. S., Lu, J., Chen, B.
10.1101/2021.08.17.456689 — Posted: 2021-08-17 Discussion: Onsite
T Cell Predominant Response to AAV-Spike Protects hACE2 Mice from SARS-CoV-2 Pneumonia
Greer, C. D., Kasden, C. M., Morales, L., Lundgreen, K. A., Hicks, P. D., Carpenter, L. J., Salas-Quinchucua, C., Tichy, E. D., Maguire, A. M., Hoffman, J. G., Bailey, R. J., Zhou, S., Luo, A., Chomistek, S. J., Kozyak, B. W., Bridges, C. R., Gordon, G. S., Tabin, G. C., Bates, P. F., Osorio, J. E., Bennett, J., Stedman, H. H.
10.1101/2021.08.16.456441 — Posted: 2021-08-17
Seasonal betacoronavirus antibodies expansion post BNT161b2 vaccination associates with reduced SARS-CoV-2 VoCs neutralization
Dispinseri, S., Marzinotto, I., Brigatti, C., Pirillo, M. F., Tolazzi, M., Bazzigaluppi, E., Canitano, A., Borghi, M., Gallinaro, A., Caccia, R., Vercesi, R., McKay, P. F., Ciceri, F., Piemonti, L., Negri, D., Cinque, P., Cara, A., Lampasona, V., Scarlatti, G.
10.1101/2021.08.15.21262000 — Posted: 2021-08-17
Efficacy and Safety of Ayurveda Intervention AYUSH 64 as add-on therapy for patients with COVID 19 infections: An open labelled, Parallel Group, Randomized controlled clinical trial
Bhardwaj, P., Godatwar, P. K., Charan, J., Sharma, S., Shafi, S., Chauhan, N., Vyas, P., Dutt, N., Midha, N., Jalandra, R., Sharma, M., Nag, V. L., Sharma, S., Singh, S. K., Sharma, P., Misra, S.
10.1101/2021.08.10.21261836 — Posted: 2021-08-17
Immunogenicity and safety of inactivated whole virion Coronavirus vaccine with CpG (VLA2001) in healthy adults aged 18 to 55: a randomised phase 1 /2 clinical trial
Lazarus, R., Taucher, C., Duncan, C., Faust, S., Green, C. A., Finn, A.
10.1101/2021.08.13.21262021 — Posted: 2021-08-17
Rapid initiation of nasal saline irrigation: hospitalizations in COVID-19 patients randomized to alkalinization or povidone-iodine compared to a national dataset
Baxter, A. L., Schwartz, K. R., Johnson, R., Rao, A., Gibson, R. W., Cherian, E., Kuchinski, A. M., Lyon, M., Schwartz, R. B.
10.1101/2021.08.16.21262044 — Posted: 2021-08-17 Discussion: Onsite
The influence of SARS-CoV-2 variants of concern on national case fatality rates
Barletta, W. A.
10.1101/2021.08.10.21261870 — Posted: 2021-08-17
Next generation infection prevention clothing: Non-woven Fabrics Coated with Cranberry Extracts Capable of Inactivating Enveloped Viruses such as SARS-CoV-2 and Multidrug-resistant Bacteria
Tunon-Molina, A., Cano-Vicent, A., Marti, M., Muramoto, Y., Noda, T., Takayama, K., Serrano-Aroca, A.
10.1101/2021.08.14.456330 — Posted: 2021-08-16
Molecular basis of a dominant SARS-CoV-2 Spike-derived epitope presented by HLA-A*02:01 recognised by a public TCR
Szeto, C., Nguyen, A. T., Lobos, C. A., Chatzileontiadou, D. S., Jayasinghe, D., Grant, E. J., Riboldi-Tunnicliffe, A., Smith, C., Gras, S.
10.1101/2021.08.15.456333 — Posted: 2021-08-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).